Insider Transactions in Q1 2023 at Onconova Therapeutics, Inc. (ONTX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 07
2023
|
Steven M Fruchtman PRESIDENT, CHIEF EXECUTIVE OFF |
SELL
Payment of exercise price or tax liability
|
Direct |
6,977
-14.7%
|
$6,977
$1.36 P/Share
|
|
Feb 07
2023
|
Steven M Fruchtman PRESIDENT, CHIEF EXECUTIVE OFF |
BUY
Exercise of conversion of derivative security
|
Direct |
21,320
+31.0%
|
-
|
|
Feb 07
2023
|
Mark Patrick Guerin CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,785
-8.94%
|
$1,785
$1.36 P/Share
|
|
Feb 07
2023
|
Mark Patrick Guerin CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,900
+25.67%
|
-
|
|
Feb 07
2023
|
Mark S. Md Gelder CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,242
-10.59%
|
$1,242
$1.36 P/Share
|
|
Feb 07
2023
|
Mark S. Md Gelder CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,833
+33.21%
|
-
|